State of Wisconsin Investment Board’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,619
Closed -$67.2K 2537
2025
Q2
$67.2K Buy
+21,619
New +$69.7K ﹤0.01% 2289
2021
Q1
Sell
-33,200
Closed -$237K 2093
2020
Q4
$237K Sell
33,200
-4,100
-11% -$39.4K ﹤0.01% 1927
2020
Q3
$398K Sell
37,300
-2,800
-7% -$32.9K ﹤0.01% 1557
2020
Q2
$506K Sell
40,100
-1,400
-3% -$16.3K ﹤0.01% 1426
2020
Q1
$380K Buy
41,500
+5,300
+15% +$60.8K ﹤0.01% 1421
2019
Q4
$505K Hold
36,200
﹤0.01% 1437
2019
Q3
$623K Buy
36,200
+6,400
+21% +$134K ﹤0.01% 1260
2019
Q2
$811K Buy
29,800
+700
+2% +$16K ﹤0.01% 1190
2019
Q1
$557K Buy
29,100
+6,600
+29% +$86K ﹤0.01% 1323
2018
Q4
$211K Hold
22,500
﹤0.01% 1451
2018
Q3
$426K Buy
22,500
+12,500
+125% +$240K ﹤0.01% 1430
2018
Q2
$195K Hold
10,000
﹤0.01% 1428
2018
Q1
$188K Hold
10,000
﹤0.01% 1404
2017
Q4
$166K Hold
10,000
﹤0.01% 1401
2017
Q3
$206K Hold
10,000
﹤0.01% 1398
2017
Q2
$90K Buy
+10,000
New +$101K ﹤0.01% 1449

Other funds holding VYGR

State of Wisconsin Investment Board's VYGR Position: Q3 2025 in Review

State of Wisconsin Investment Board sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 21,619 shares — an estimated $67.2K sold.

State of Wisconsin Investment Board first reported a position in VYGR in Q2 2017 and held it in 16 quarters. The position peaked at $811K in Q2 2019. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • State of Wisconsin Investment Board reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 21,619 Voyager Therapeutics shares in Q3 2025, an estimated $67.2K.
  • State of Wisconsin Investment Board first reported a position in Voyager Therapeutics in Q2 2017 and held it in 16 quarters.
  • State of Wisconsin Investment Board's Voyager Therapeutics position peaked at $811K in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.